Work

Targeting PEAK1 sensitizes anaplastic thyroid carcinoma cells harboring BRAFV600E to Vemurafenib by Bim upregulation.

Year: 2024

Type: article

Abstract: to vemurafenib.

Source: PubMed

DOI: 10.14670/hh-18-705

Authors: Qiuhan Wang, Fengyun Hao, Liang Ning, Chong Sun

Institutions: Qingdao University, Affiliated Hospital of Qingdao University

Language: English

Topic: Thyroid Cancer Diagnosis and Treatment

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4394738345

FWCI: 0.815

Cites: 21

Cited by: 3

Related to: 10